Standalone figures · ₹ crore · years without a filed annual are summed from quarters
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,407 | 2,808 | 3,148 | 3,916 | 3,906 | 3,512 | 4,993 | 5,062 | 4,358 | 5,075 | 5,564 | |
| COGS | -1,226 | -1,360 | -1,693 | 2,058 | 1,881 | 1,601 | 2,624 | 2,682 | 2,373 | 2,622 | 3,066 |
| Gross profit | — | — | — | 1,858 | 2,025 | 1,911 | 2,368 | 2,380 | 1,985 | 2,453 | 2,497 |
| 3,252 | 3,763 | 4,368 | 1,122 | 1,181 | 1,065 | 1,505 | 1,684 | 1,423 | 1,743 | 1,717 | |
| 380 | 405 | 472 | 736 | 844 | 846 | 863 | 696 | 561 | 710 | 781 | |
| OPM % | 15.8% | 14.4% | 15% | 18.8% | 21.6% | 24.1% | 17.3% | 13.7% | 12.9% | 14% | 14% |
| Depreciation | 62 | — | 105 | 112 | 117 | 120 | 146 | 163 | 184 | 213 | 216 |
| Interest | 26 | 21 | 9 | 4 | 2 | 2 | 3 | 2 | 2 | 6 | 4 |
| 46 | 42 | 38 | 31 | 78 | 104 | 90 | 199 | 135 | 133 | 199 | |
| Profit before tax | 393 | 401 | 397 | 652 | 803 | 828 | 804 | 730 | 510 | 623 | 774 |
| Tax | 125 | 115 | 127 | 223 | 162 | 197 | 196 | 178 | 125 | 167 | 179 |
| Tax % | 31.8% | 28.8% | 31.9% | 34.3% | 20.2% | 23.8% | 24.4% | 24.4% | 24.5% | 26.8% | 23.1% |
| 268 | 285 | 270 | 429 | 640 | 631 | 608 | 552 | 385 | 456 | 595 | |
| PAT margin % | 11.1% | 10.2% | 8.6% | 11% | 16.4% | 18% | 12.2% | 10.9% | 8.8% | 9% | 10.7% |
| EPS (₹) | 90.4 | 96.2 | 91.2 | 144.5 | 215.8 | 212.8 | 205.3 | 50.2 | 130.4 | 155 | 202.1 |
| EPS adjusted (₹) | — | — | — | — | 215.7 | 213.1 | 205.2 | 187 | 130.5 | 154.9 | 202 |
| 11.1% | 10.4% | 13.2% | 10.4% | 12.7% | 9.4% | 15.8% | 49.8% | 15.3% | 16.1% | 14.8% | |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 30 | 30 | 30 | 30 | 29 | 29 | 29 |
| Reserves | — | 3,682 | 4,287 | 4,560 | 5,060 | 5,509 | 6,026 |
| — | 0 | 73 | 8 | 11 | 8 | 7 | |
| — | 876 | 961 | 833 | 905 | 1,005 | 1,234 | |
| Total equity & liabilities | — | 4,587 | 5,351 | 5,431 | 6,005 | 6,551 | 7,297 |
| 904 | 1,056 | 1,273 | 1,345 | 1,654 | 1,739 | 1,640 | |
| CWIP | — | 239 | 173 | 356 | 217 | 91 | 81 |
| Investments | — | 1,554 | 1,554 | 1,131 | 2,463 | 2,832 | 3,448 |
| — | 1,739 | 2,350 | 2,598 | 1,671 | 1,889 | 2,128 | |
| Total assets | — | 4,587 | 5,351 | 5,431 | 6,005 | 6,551 | 7,297 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Performance and Other Chemicals | 4,608.73 | 85.51 | 3,861.45 | 924.58 | 2,936.87 | 2.91 |
| Life Science Chemicals | 1,805.24 | 417.06 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 677 | 217 | 732 | 624 | 427 | 716 | |
| -603 | -225 | -498 | -483 | -366 | -621 | |
| -64 | 11 | -252 | -133 | -68 | -79 | |
| Net cash flow | 10 | 3 | -18 | 8 | -7 | 16 |
| Free cash flow | 406 | -80 | 282 | 281 | 236 | 587 |
| CFO / Operating profit % | 79.9% | 25.1% | 105.2% | 111.1% | 60.2% | 91.7% |
| 1,379.25 |
| 305.45 |
| 1,073.8 |
| 38.84 |
| Others | 80.39 | 11.84 | 240.92 | 21.33 | 219.59 | 5.39 |
₹ crore by fiscal year